MedPath

Clinical study to test effectiveness of a beverage sweetened with Isomaltulose on the blood glucose levels.

Not Applicable
Conditions
Healthy volunteers with metabolic risk (BMI 25 - 40 kg/m²)
Registration Number
DRKS00022150
Lead Sponsor
Technische Universität München Lehrstuhl für Ernährungsmedizin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
15
Inclusion Criteria

written declaration of consent
- 20 - 50 years
- BMI 25 - 40 kg / m²
- women, men (in a ratio of 1: 1)

Exclusion Criteria

- No declaration of consent
- Current participation in another intervention study
- Chronic diseases (medical diagnosis according to the test persons):
- Diabetes mellitus
- Untreated hypertension (> 160/95 mmHg)
- Untreated endocrinological diseases (e.g. hyperthyroidism or -underfunction)
- Diagnosed, Chronic liver diseases (e.g. HBV, HCV)
- Diagnosed autoimmune disease (e.g. rheumatism, ulcerative colitis, Crohn's disease)
- Chronic infections (e.g. HIV)
- Cardiovascular or tumor disease
- Acute infectious disease
- Known allergies or intolerances to the tested food
- Pregnancy and breast feeding period
- Blood donation in the past 3 months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath